You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACR

Showing 26 - 50 of 2,181
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardio-respiratory Arrest, Prolactin Trial in Nice (venous lactate)

Completed
  • Cardio-respiratory Arrest, Prolactin
  • venous lactate
  • Nice, Provences Alpes Cote d'Azur, France
    CHU de Nice
Apr 11, 2022

Klotho and Mineral Bone Density in Systemic Sclerosis

Recruiting
  • Systemic Sclerosis
  • Possible Klotho effects on SSc clinical conditions, namely skeletal, fibrotic and microangiopathic damage
  • Evalution in healthy patients of bone mineral density, Klotho level and key bone-related cytokines
  • Rome, Lazio, Italy
    Division of Rheumatology, Fondazione Policlinico Universitario A
Mar 8, 2023

Liver Transplant; Complications, Vitamin D Deficiency Trial (vitamin D supplementation, control)

Not yet recruiting
  • Liver Transplant; Complications
  • Vitamin D Deficiency
  • vitamin D supplementation
  • control
  • (no location specified)
Oct 5, 2022

Early Screening and Diagnosis of CKD

Recruiting
  • Kidney; Disease (Functional)
  • Chronic Kidney Disease
  • 99mTc-DTPA
  • Nanjing, Jiangsu, China
    Nanjing First Hospital, Nanjing Medical University
Apr 5, 2022

Irritable Bowel Syndrome Trial in United States (Olorinab, Placebo)

Terminated
Has Results
  • Irritable Bowel Syndrome
  • Birmingham, Alabama
  • +68 more
Sep 15, 2022

Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)

Not yet recruiting
  • Antibody-mediated Rejection
  • Lung Transplant Rejection
  • Extracorporeal Photopheresis
  • (no location specified)
Oct 30, 2023

Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Chronic Kidney Diseases
  • Empagliflozin 10 MG
  • Placebo
  • (no location specified)
Oct 30, 2023

Rheumatoid Arthritis Trial (SAR441566, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 4, 2023

Rheumatoid Arthritis Trial (SBD121, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • SBD121
  • Placebo
  • (no location specified)
Aug 16, 2023

Hyperuricemia Trial (Dual-energy CT (DECT) and ultrasound)

Not yet recruiting
  • Hyperuricemia
  • Dual-energy CT (DECT) and ultrasound
  • (no location specified)
Jun 27, 2022

Rheumatoid Arthritis, Therapy Trial in Jinan (Iguratimod)

Recruiting
  • Rheumatoid Arthritis
  • Therapy
  • Jinan, Shandong, China
    Yanfeng Hou
Nov 24, 2023

Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)

Completed
  • Rheumatoid Arthritis (RA)
  • Daegu, Korea, Republic of
  • +9 more
Aug 26, 2021

A Randomised Controlled Trial

Active, not recruiting
  • Diabetes
  • Chronic Kidney Diseases
  • Minuteful Kidney Test Kit
  • Essex, United Kingdom
  • +5 more
Jul 20, 2023

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Rheumatoid Arthritis Trial in Beijing (bortezomib)

Not yet recruiting
  • Rheumatoid Arthritis
  • Beijing, China
    Peking Union Medical College Hospital
Apr 6, 2023

Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

Recruiting
  • Arthritis, Rheumatoid
  • Placebo
  • +2 more
  • Upland, California
  • +2 more
Sep 1, 2023

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Not yet recruiting
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 25, 2023

Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Ursodeoxycholic acid (UDCA) 500 mg)

Recruiting
  • Rheumatoid Arthritis
  • Placebo
  • Ursodeoxycholic acid (UDCA) 500 mg
  • Shibīn Al Kawm, Egypt
    Menoufia University Hospital
Aug 1, 2023

Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)

Recruiting
  • Rheumatoid Arthritis
  • AP1189, 60 mg
  • +3 more
  • Chișinău, Moldova, Republic of
    Timofei Mosneaga Republican Clinical Hospital
Jan 5, 2023

Application of N-of-1 Rheumatoid Arthritis

Not yet recruiting
  • Arthritis, Rheumatoid
  • Boston, Massachusetts
    Tufts Medical Center
Aug 24, 2023

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)

Not yet recruiting
  • Juvenile Psoriatic Arthritis
  • (no location specified)
Oct 20, 2023

Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)

Recruiting
  • Still's Disease, Juvenile Onset
  • Still's Disease, Adult-Onset
  • Chiba-shi, Chiba, Japan
  • +17 more
Apr 3, 2023

Dermatomyositis Trial in Paris (Baricitinib, Placebo)

Not yet recruiting
  • Dermatomyositis
  • Paris, France
    Pitie-Salpêtrière hospital APHP
Jun 7, 2022

Sickle Cell Disease (SCD) Trial in Worldwide (Crizanlizuamb, Standard of Care)

Active, not recruiting
  • Sickle Cell Disease (SCD)
  • Birmingham, Alabama
  • +24 more
Jan 12, 2023